Table 10.
Autologous fat tissue grafting: indications and use.
| At your center, are procedures of autologous fat tissue grafting or lipofilling performed? | |||
|---|---|---|---|
| Yes | 92,31 % | 60 | 65 |
| No | 7,69 % | 5 | |
| If no why ? | |||
| I do not consider it oncologically safe | 1,54 % | 1 | 65 |
| I do not have operating rooms available to include this procedure | 4,62 % | 3 | |
| I do not consider it useful | 1,54 % | 1 | |
| I answered yes | 92,31 % | 60 | |
| Per quanto riguarda la safety del tessuto adiposo autologo presso il tuo centro si seguono particolari attenzioni (più risposte possibili): | |||
| The indication for lipofilling is discussed in a multidisciplinary consultation | 43,08 % | 28 | 65 |
| Lipofilling is not performed in patients who have undergone (demolitive) surgery less than two years ago. | 16,92 % | 11 | |
| Lipofilling is not performed in triple negative patients | 4,62 % | 3 | |
| Lipofilling is not performed in LUMINAL B patients | 3,08 % | 2 | |
| At my center, the procedure is performed in all patient classes. | 44,62 % | 29 | |
| Other (specify) | 6,15 % | 4 | |
| Do you use autologous fat tissue grafting following prepectoral reconstruction? | |||
| 51–70 % cases | 9,23 % | 6 | 65 |
| Between 11 and 50 % of cases | 24,62 % | 16 | |
| Between 5 and 10 % cases | 18,46 % | 12 | |
| Less than 5 % | 16,92 % | 11 | |
| Never | 30,77 % | 20 | |